Health
Johnson & Johnson’s COVID-19 vaccine shows promising response in early trial after one dose – WSYM-TV
Results from early stage trials of Johnson & Johnsons COVID-19 vaccine are promising, showing the one-dose vaccine generates an immune response in nearly all volunteers, with minimal side effects.
The company plans to release more details in a few weeks, and apply for emergency use authorization from the FDA in February.
Researchers say
Phase 1-2 of the vaccine showed either one or two doses of the vaccine generated both antibody and T-cell responses against the coronavirus. The vaccines efficacy,…
-
Noosa News8 hours agoArnie the dog found dead in stolen ute after week of searching
-
Noosa News8 hours ago‘Beyond devastated’ Brisbane family learn missing German shepherd Arnie found dead in back of stolen car
-
Noosa News13 hours agoTeenage girl dies in hit-and-run, police hunt for ute
-
Noosa News15 hours agoTeenage girl killed in alleged hit-and-run at Margate north of Brisbane